Therapeutics. Medical search. Frequent questions

Proteon Therapeutics Craters on Missed Late-Stage Results (NASDAQ: PRTO) - 24/7 Wall St". 24/7 Wall St. Retrieved 2017-02-28. (wikipedia.org)
CELEBRATION, Fla., March 01, 2023 (GLOBE NEWSWIRE) -- Zevra Therapeutics (NasdaqGS: ZVRA) ("Zevra" or the "Company" and formerly KemPharm, Inc.), a rare disease therapeutics company, announced today that it will begin trading under the new ticker symbol "ZVRA" on the Nasdaq Global Select Market at market open today, March 1, 2023. (yahoo.com)
Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced the Company has submitted a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) seeking approval of EB-101, its investigational autologous, engineered cell therapy, as a treatment for patients with recessive dystrophic epidermolysis bullosa (RDEB). (biospace.com)
Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced the appointment of Madhav Vasanthavada, Ph.D., M.B.A. to the role of Chief Commercial Officer (CCO) and Head of Business Development (BD), effective immediately. (biospace.com)
Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced that members of its management team will participate in upcoming investor conferences in September 2023. (biospace.com)
Abeona Therapeutics Inc. (Nasdaq: ABEO) today reported financial results for the second quarter of 2023 and provided an update on progress toward achieving key corporate objectives. (biospace.com)
Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced that it has completed the submission of the briefing package to the U.S. Food and Drug Administration (FDA) for the Company's pre-Biologics License Application (BLA) meeting in August 2023. (biospace.com)
Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced that it has joined the Rare Disease Company Coalition (RDCC), an alliance of life science companies committed to discovering, developing, and delivering therapies for patients impacted by rare diseases. (biospace.com)
Abeona Therapeutics Inc. (Nasdaq: ABEO) announced the closing of its previously announced registered direct offering for total gross proceeds of $25 million, before deducting the placement agents' fees and other offering expenses. (biospace.com)
Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced that it has raised $25 million at-the-market from select existing investors, primarily to fund initiation of the Company's launch preparations in anticipation of the EB-101 Biologics License Application (BLA) submission and potential approval. (biospace.com)
Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced that it received feedback from the U.S. Food and Drug Administration (FDA) on June 8, 2023, in which the Company gained the Agency's alignment on the data required to establish retroviral vector (RVV) comparability, a critical Chemistry, Manufacturing and Controls (CMC) component for the EB-101 Biologics License Application (BLA). (biospace.com)
Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced that Vish Seshadri, Chief Executive Officer, will participate in a fireside chat at the Jefferies Healthcare Conference on Friday, June 9, 2023 at 9:00 a.m. (biospace.com)
Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced it has changed the date of its previously announced First Quarter 2023 Portfolio Update conference call and webcast to Wednesday, May 24, 2023, at 8:30 a.m. (biospace.com)
Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company focused on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of muscular and other select diseases, announced today its financial results for the third quarter ended September 30, 2023 and provided a corporate update. (biospace.com)
Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company focused on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of muscular and other select diseases, today announced data from two late-breaking posters presented at this year's 28th International Annual Congress of the World Muscle Society (WMS) which took place in Charleston, South Carolina, from October 3-7, 2023. (biospace.com)
Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company focused on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of muscular and other select diseases, announced today its financial results for the second quarter ended June 30, 2023 and provided a corporate update. (biospace.com)
Capricor Therapeutics (NASDAQ: CAPR) today announced positive 24-month safety and efficacy results from its ongoing HOPE-2 open label extension (OLE) study with its lead asset, CAP-1002, for the treatment of Duchenne muscular dystrophy (DMD). (biospace.com)
MINNEAPOLIS, March 15, 2018 (GLOBE NEWSWIRE) -- Precision Therapeutics Inc. (NASDAQ:AIPT) ("Precision" or "the Company"), formerly Skyline Medical, announced today that its wholly owned subsidiary, TumorGenesis Inc., has secured a license agreement with 48Hour Discovery ("48HD") which grants it access to 48HD's ligand discovery technology. (globenewswire.com)
Precision Therapeutics (NASDAQ:AIPT) operates in two business areas: first, applying artificial intelligence to personalized medicine and drug discovery to provide personalized medicine solutions for clients in the pharmaceutical, diagnostic, and biotech industries, and second, production of the FDA-approved STREAMWAY® System for automated, direct-to-drain medical fluid disposal. (globenewswire.com)
NEW YORK, Aug. 10, 2023 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, today reported financial results for the second quarter ended June 30, 2023. (yahoo.com)
GAINESVILLE, Fla.--( BUSINESS WIRE )-- Cyclo Therapeutics, Inc. (Nasdaq: CYTH) ("Cyclo Therapeutics" or the "Company"), a clinical stage biotechnology company dedicated to developing life-changing medicines through science and innovation for patients and families living with diseases, today announced that it has commenced the commercial-scale production of batches of Trappsol ® Cyclo™, the Company's proprietary formulation of hydroxypropyl beta cyclodextrin. (businesswire.com)

Pittsburgh, Oct. 24, 2018 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc. , a clinical stage neuroscience company focused on synaptic protection and restoration in Alzheimer's disease and other neurodegenerative disorders, today announced its sponsorship of the Third International Symposium on Sigma-2 Receptors: Role in Health and Disease . (globenewswire.com)
LAUSANNE, Switzerland, June 01, 2023 (GLOBE NEWSWIRE) -- ADC Therapeutics SA (NYSE: ADCT) today announced that Ameet Mallik, Chief Executive Officer, will participate in a fireside chat at the Jefferies Healthcare Conference in New York City on Thursday, June 8th at 8:30 a.m. (tmcnet.com)

The Cellular and Molecular Therapeutics Laboratory, led by Dr. John F. Tisdale, is working on multiple strategies both in the laboratory and in the clinic to cure sickle cell disease by repairing or replacing the precursor bone marrow cells that give rise to sickled red blood cells. (nih.gov)
UMass Chan Medical School has established the Translational Institute for Molecular Therapeutics, ushering in the next phase of gene therapy development to accelerate new treatments for rare genetic diseases. (umassmed.edu)
The Translational Institute for Molecular Therapeutics was formed to evaluate therapies for rare diseases, where there are few options for seeking treatment. (umassmed.edu)
Researchers working with UMass Chan Medical School's Translational Institute for Molecular Therapeutics announced progress in developing a vector to deliver gene replacement therapy in mice models with Cockayne syndrome, a rare and fatal neurodegenerative disease that largely affects children and young adults. (umassmed.edu)
Top story: The Translational Institute for Molecular Therapeutics leverages UMass Chan Medical School's extensive experience in researching and developing gene therapies for early-stage clinical trials. (umassmed.edu)
In a piece written for The Conversation, Miguel Sena-Esteves, PhD, talks about research leading to the first ever gene therapy for Tay-Sachs disease and the launch of the Translational Institute for Molecular Therapeutics at UMass Chan. (umassmed.edu)

With exclusive access to new treatments, the Experimental Therapeutics Program at Children's National offers renewed hope for a good outcome to all families. (childrensnational.org)
We offer experimental therapeutics for many types of cancer. (childrensnational.org)
The Experimental Therapeutics (ET) Program provides an organized integrated infrastructure that enables both clinical translation of basic and population science research from Simmons research programs and identification of clinically relevant hypotheses for testing by the Center's basic science programs. (utsouthwestern.edu)

IKT ) ("Inhibikase"), a clinical-stage pharmaceutical company developing therapeutics for Parkinson's disease and related disorders that arise inside and outside of the brain, announced today the closing of its initial public offering of 1,800,000 shares of common stock at a public offering price of $10.00 per share. (prnewswire.com)
Inhibikase is a clinical-stage pharmaceutical company developing therapeutics for Parkinson's Disease and related disorders that arise inside and outside of the brain. (prnewswire.com)
On Tuesday (11 August), Bayer announced plans to acquire UK-based clinical-stage biotech company, Kandy Therapeutics. (siliconrepublic.com)
Bellerophon Therapeutics a clinical-stage biotherapeutics company focused on developing innovative products at the intersection of drugs and devices that address significant unmet medical needs in the treatment of cardiopulmonary diseases. (annualreports.com)
Cyclo Therapeutics, Inc. is a clinical-stage biotechnology company dedicated to developing life-changing medicines through science and innovation for patients and families suffering from disease. (businesswire.com)

Megan Coder, Executive Director of the Digital Therapeutics Alliance (the professional org founded in 2017 to guide the development of the category), swings by to level set with some definitions, talk reimbursement trends in US and Europe, and explain the intention behind the DTA's recently published code of conduct and best practices for DTX companies. (thehealthcareblog.com)
WTF are Digital Therapeutics? (thehealthcareblog.com)
Digital therapeutics has exploded as the new hot buzzword in digital health. (thehealthcareblog.com)
But how are digital therapeutics different from digital health applications, applied health signals, or m-health technologies? (thehealthcareblog.com)
The Digital Therapeutics Alliance was formed to answer that exact question. (thehealthcareblog.com)

Dr. Carl Schwartz, Chief Executive Officer of Precision Therapeutics, commented, "TumorGenesis is developing a better way to grow tumors outside the human body so they mimic the environment inside the patients' body as closely as possible. (globenewswire.com)
This milestone brings us one step closer to our ultimate goal of providing patients, families and caregivers with hope and a potential treatment option for two diseases with significant unmet need," added N. Scott Fine, Chief Executive Officer of Cyclo Therapeutics. (businesswire.com)

Early access programs are made available by Zevra Therapeutics, Inc. and its affiliates and are subject to the Company's Early Access Program ("EAP") policy as published on its website at zevra.com . (yahoo.com)
Capricor Therapeutics announced an update on the Company's positive Type-B clinical meeting with the U.S. Food and Drug Administration on the design and execution of HOPE-3, Capricor's pivotal Phase 3 trial with lead asset CAP-1002 in treating Duchenne muscular dystrophy. (biospace.com)
Following a Type B interaction with the FDA, Cyclo Therapeutics received positive feedback supporting the Company's development strategy to submit an Initial New Drug (IND) application for a Phase 2 study of intravenous Trappsol ® Cyclo™ in the treatment of early Alzheimer's disease. (businesswire.com)

Add Nektar Therapeutics to My Watchlist. (aol.com)

Zevra Therapeutics is a rare disease company melding science, data, and patient need to create transformational therapies for diseases with limited or no treatment options. (yahoo.com)
Drive partnerships with Pharma companies for the development of new therapies, generating revenues for Precision Therapeutics. (globenewswire.com)
While currently focused on cancer, Seattle Children's Therapeutics plans to expand our focus to a host of other diseases that selectively afflict children and that are amenable to treatment using genetic and cellular therapies. (seattlechildrens.org)
While Seattle Children's Therapeutics is currently focused on cancer, in the next five years Seattle Children's Therapeutics will move into designing and developing cell and gene therapies for other life-threatening and debilitating diseases that afflict children. (seattlechildrens.org)

Cognition Therapeutics is a privately held biopharmaceutical company focused on the protection and restoration of synaptic function in neurocognitive disorders through a pipeline of disease-modifying small molecule drug candidates. (globenewswire.com)
Chemomab Therapeutics Ltd, formerly known as Anchiano Therapeutics Ltd, is a Israel-based biopharmaceutical company. (stockhouse.com)

Kandy was founded in 2017 as a spin-out of Nerre Therapeutics and has been backed by life sciences investors such as Advent Life Sciences, Fountain Healthcare Partners, Forbion Capital Partners, OrbiMed and Longitude Capital. (siliconrepublic.com)

Precision Therapeutics' CRO services business is committed to improving the effectiveness of cancer therapy using the power of artificial intelligence (AI) applied to rich data diseases databases. (globenewswire.com)
This information provides insight not only into the management of coronavirus diseases but also into the relative success of different approaches to identifying candidate therapeutics against an emerging disease. (nih.gov)
The COBRE Center for Targeted Therapeutics (CTT) was created to attract and foster the professional development of talented junior scientists who are motivated to make a difference in the treatment of debilitating diseases. (sc.edu)
Targeted therapeutics is research that seeks to develop new and more effective classes of drugs against various diseases by aiming these drugs at molecular and cellular targets that play a key role in the disease. (sc.edu)
The Center for Targeted Therapeutics currently supports four research projects led by junior faculty members with expertise in cancer biology and genomics, signal transduction, metabolic diseases and nanotechnology-based drug delivery. (sc.edu)
Through pilot projects and collaborative studies, CTT research will encompass targeted therapeutics for multiple diseases. (sc.edu)

The team that currently makes up Seattle Children's Therapeutics has designed, manufactured and launched a robust portfolio of immunotherapy clinical trials for childhood cancer since 2012 in the areas of leukemia and lymphoma , brain tumors and solid tumors . (seattlechildrens.org)

A video introduction to the Biodiscovery program at the Centre for Biodiscovery & Molecular Development of Therapeutics. (edu.au)
Centre For Biodiscovery & Molecular Development of Therapeutics Professor Alex Loukas, Dr Severine Navarro and their team are collaborating with Janssen to develop a treatment for inflammatory bowel disease based on proteins secreted by hookworms. (edu.au)
Unitat Mixta d'investigació IRTA-UAB en Sanitat Animal, Centre de Recerca en Sanitat Animal (CReSA) and Departament de Sanitat i Anatomia Animals, Facultat de Veterinàriaia, Universitat Autònoma de Barcelona, Spain. (bvsalud.org)

2016. https://www.unboundmedicine.com/washingtonmanual/view/Washington-Manual-of-Medical-Therapeutics/602571/all/Miscellaneous. (unboundmedicine.com)

While there are currently no treatments specifically approved for monkeypox, therapeutics developed for patients with smallpox have been deployed during the current outbreak. (cdc.gov)
This Health Alert Network (HAN) Health Update provides clinicians and public health officials with new information about managing monkeypox in patients requiring therapeutics. (cdc.gov)
Highlights therapeutics, including cidofovir, brincidofovir, and vaccinia immune globulin intravenous (VIGIV), each of which can be administered concurrently with tecovirimat for certain patients with (or at high risk for) severe monkeypox. (cdc.gov)
Monkeypox (Mpox) requires continued surveillance, vaccines, therapeutics and mitigating strategies. (bvsalud.org)

Regarding regulatory submission plans in Europe, Applied Therapeutics and its European commercial partner, Advanz Pharma, met with the European Medicines Agency (EMA) rapporteurs, and plan to proceed with an EMA Marketing Authorization Application (MAA) submission as expeditiously as possible. (yahoo.com)
In addition, WHO supported PICs by providing trainings in clinical management of COVID-19, developing critical supply needs estimates, and facilitating regulatory approval of clinical therapeutics, including emergency use authorization. (who.int)

Capricor Therapeutics announced that the Company will host a webinar with the nonprofit organization Parent Project Muscular Dystrophy to review key regulatory details and provide clinical updates that support the advancement of its ongoing HOPE-3, Phase 3 clinical trial of CAP-1002 for treating Duchenne muscular dystrophy. (biospace.com)
Capricor Therapeutics today announced that the Company has appointed Michael Kelliher to its Board of Directors, effective immediately. (biospace.com)
This business has launched with Precision Therapeutics' investment in Helomics Corporation, a precision diagnostic company and integrated clinical contract research organization whose mission is to improve patient care by partnering with pharmaceutical, diagnostic, and academic organizations to bring innovative clinical products and technologies to the marketplace. (globenewswire.com)

Allergan will make Molecular Partners a combined up-front payment of $62.5 million as part of two new agreements centered on the discovery, development, and commercialization of DARPin® (Designed Ankyrin Repeat Protein) therapeutics for treating serious ophthalmic disorders. (genengnews.com)
In addition to ZYNLONTA, ADC Therapeutics has multiple ADCs in ongoing clinical and preclinical development. (tmcnet.com)

Aera Therapeutics is announcing its launch today, they said, with "a vision to harness its proprietary delivery platform to unlock the potential of genetic medicines. (genengnews.com)

The Therapeutics Initiative is part of the Department of Anesthesiology, Pharmacology & Therapeutics at UBC's Faculty of Medicine. (ubc.ca)
This topic was chosen because of its societal impact, the emergence of common technologies driving therapeutics research in different disease areas and the presence of a critical core of senior faculty with broad acumen and transdisciplinary vision in targeted therapeutics. (sc.edu)

Irish life sciences venture capital fund Fountain Healthcare Partners is set to benefit from Bayer's $425m acquisition of Kandy Therapeutics. (siliconrepublic.com)
As a global leader in women's healthcare, Bayer is an ideal partner for Kandy Therapeutics to continue to the progress and optimise NT-814 as a potential treatment option. (siliconrepublic.com)

In addition to scientific presentations by the speakers, Susan Catalano, Ph.D. , founder and chief science officer of Cognition Therapeutics and Nicholas J. Izzo, Ph.D., principal scientist at Cognition Therapeutics, will report and discuss recent clinical trial outcomes of Elayta™, a sigma-2 receptor antagonist, in patients with Alzheimer's disease. (globenewswire.com)

Thought you might appreciate this item(s) I saw in Journal of Cancer Research and Therapeutics. (lww.com)

The scale of the COVID-19 crisis offers a rare opportunity to collect data on the effects of candidate therapeutics. (nih.gov)

In September 2019, Proteon Therapeutics merged with ArTara Therapeutics. (wikipedia.org)

To date, a small number of therapeutics have already been authorized by regulatory agencies such as the Food and Drug Administration (FDA), while most remain under investigation. (nih.gov)

A live webcast of the presentation will be available via the Events & Presentations page in the Investors section of ADC Therapeutics' website, ir.adctherapeutics.com . (tmcnet.com)

The CAR T-cell products used in our immunotherapy clinical trials are made on-site in our Therapeutics Cell Manufacturing facility . (seattlechildrens.org)
Cyclo Therapeutics' robust, scalable and validated manufacturing process has been a cornerstone of our capabilities and enables us to move forward with all of our patient treatment programs," said Jeffrey L. Tate, Ph.D., Chief Operating Officer and Chief Quality Officer of Cyclo Therapeutics. (businesswire.com)

Enter Center for Targeted Therapeutics in the Search Funds by Name field then follow the prompts to complete and submit the form. (sc.edu)

Dental materia medica, therapeutics and prescription writing. (upenn.edu)

If you are interested in partnering with Seattle Children's Therapeutics, please email us . (seattlechildrens.org)
If you are interested in learning more about how your donation can support Seattle Children's Therapeutics' critical work, please contact Brei Haywood, program manager at Seattle Children's Foundation, by email or at 206-987-1087 . (seattlechildrens.org)
Then subscribe to receive email notices of upcoming Therapeutics Letters, educational events, and other announcements. (ubc.ca)

Today, Seattle Children's Therapeutics encompasses Seattle Children's cancer immunotherapy research program. (seattlechildrens.org)

Kriya Therapeutics Inc., with dual headquarters in Durham and Palo Alto, Calif., has acquired a gene therapy startup that Kriya says will align with its approach to treating metabolic disease. (zoominfo.com)

ADC Therapeutics' CD19-directed ADC ZYNLONTA (loncastuximab tesirine-lpyl) received accelerated approval by the FDA and conditional approval from the European Commission for the treatment of relapsed or refractory diffuse large B-cell lymphoma after two or more lines of systemic therapy. (tmcnet.com)
Cyclo Therapeutics is also planning to evaluate Trappsol ® Cyclo™ for the treatment of Alzheimer's disease, targeting the reduction of amyloid beta and tau. (businesswire.com)
Most patients with indications for tecovirimat do not require treatment with any additional therapeutics. (cdc.gov)
Most PICs have faced challenges accessing therapeutics recommended for the treatment of COVID-19 due to their high demand worldwide and supply chain constraints. (who.int)

Will Nektar Therapeutics Beat These Analyst Estimates? (aol.com)

EXCLUSIVE: Pasithea Therapeutics Says 'Ketamine, when used at sub-anesthetic doses, has been shown to be highly effective in treating some psychiatric disorders. (benzinga.com)

The Antibiotic Era: Reform, Resistance, and the Pursuit of a Rational Therapeutics takes a unique approach by presenting a well-documented history, starting in the earliest days with the introduction of antimicrobial drugs to the present time. (cdc.gov)

Anatomy12

Organisms15

Diseases21

Chemicals and Drugs76

Analytical, Diagnostic and Therapeutic Techniques and Equipment58

Psychiatry and Psychology2

Phenomena and Processes46

Disciplines and Occupations21

Anthropology, Education, Sociology and Social Phenomena7

Technology, Industry, Agriculture22

Information Science7

Health Care10

NASDAQ21

GLOBE NEWSWIRE2

Molecular Therapeutics6

Experimental Therapeutics3

Clinical-stage5

Digital Therapeutics5

Chief Executi2

Company's3

Watchlist1

Therapies4

Biopharmaceutical2

Founded in 20171

Diseases6

Tumors1

Centre3

20161

Monkeypox4

Authorization2

Company3

Development2

Genetic1

Faculty2

Healthcare2

Outcomes1

Cancer Research1

Data1

20191

Regulatory1

Investors1

Manufacturing2

Search1

Prescription1

Email3

Program1

Gene therapy1

Treatment4

Estimates1

Disorders1

Resistance1